Accelerating Market Readiness with Integrated Evidence Planning

A small pharmaceutical company needed a strong evidence base to support its product launch, justify pricing, and gain regulatory and payer approvals. However, siloed efforts and unclear market positioning created challenges.

Challenges:

• Fragmented evidence generation led to inefficiencies.
• Unclear patient targeting made market positioning difficult.
• Regulatory and payer hurdles threatened approval and reimbursement.

Axtria's Solution:

• Systematic Literature Review to identify gaps
• Real-World Data Analysis to quantify disease burden
• Economic Modeling to demonstrate cost-effectiveness

The Impact:

By integrating insights gained from integrated evidence planning, the client strengthened its market positioning, secured a compelling economic argument for payers, and ensured a smoother path to regulatory approval. The iterative approach also created a foundation for future evidence generation, streamlining post-launch studies.

Result:

A well-supported product launch with a clear value proposition, optimized market access, and increased stakeholder confidence.

Download the complete case study to learn more.

Contact us at connect@axtria.com with any questions.